Transendothelial glucose transport is not restricted by extracellular hyperglycaemia

Vascular Pharmacology

Volumn 87, Issue , 2016, Pages 219-229

  Tumova, Sarka ^a   Kerimi, Asimina ^a   Porter, Karen E ^b   Williamson, Gary ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Diabetes; Endothelial cell; Glucose transport; Hyperglycaemia; Shear stress

Indexed keywords

CARBON 14; GLUCOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 12; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 6; LIPID; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; FRUCTOSE;

AORTA; ARTICLE; CELL COUNT; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; GENE SILENCING; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HYPERGLYCEMIA; LIPID STORAGE; PRIORITY JOURNAL; SAPHENOUS VEIN; SKIN BLOOD VESSEL; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; CELL CULTURE; CYTOLOGY; ENDOTHELIUM CELL; METABOLISM;

AORTA; CELLS, CULTURED; ENDOTHELIAL CELLS; FRUCTOSE; GENE KNOCKDOWN TECHNIQUES; GLUCOSE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPERGLYCEMIA; RNA, MESSENGER; SAPHENOUS VEIN;

EID: 85006515958     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2016.11.001     Document Type: Article

References (78)

1. [1] Bauer, V., Sotnikova, R., Nitric oxide—the endothelium-derived relaxing factor and its role in endothelial functions. Gen. Physiol. Biophys. 29 (2010), 319–340.
2. [2] Durand, M.J., Gutterman, D.D., Diversity in mechanisms of endothelium-dependent vasodilation in health and disease. Microcirculation 20 (2013), 239–247.
3. [3] Ellinsworth, D.C., Earley, S., Murphy, T.V., Sandow, S.L., Endothelial control of vasodilation: integration of myoendothelial microdomain signalling and modulation by epoxyeicosatrienoic acids. Pflugers Arch. 466 (2014), 389–405.
4. [4] Galley, H.F., Webster, N.R., Physiology of the endothelium. Br. J. Anaesth. 93 (2004), 105–113.
5. [5] Aird, W.C., Endothelial cell heterogeneity. Cold Spring Harb. Perspect. Med., 2, 2012, a006429.
6. [6] Stan, R.V., Endothelial stomatal and fenestral diaphragms in normal vessels and angiogenesis. J. Cell. Mol. Med. 11 (2007), 621–643.
7. [7] Nolan, D.J., Ginsberg, M., Israely, E., Palikuqi, B., Poulos, M.G., James, D., Ding, B.S., Schachterle, W., Liu, Y., Rosenwaks, Z., Butler, J.M., Xiang, J., Rafii, A., Shido, K., Rabbany, S.Y., Elemento, O., Rafii, S., Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration. Dev. Cell 26 (2013), 204–219.
8. [8] Tajes, M., Ramos-Fernandez, E., Weng-Jiang, X., Bosch-Morato, M., Guivernau, B., Eraso-Pichot, A., Salvador, B., Fernandez-Busquets, X., Roquer, J., Munoz, F.J., The blood-brain barrier: structure, function and therapeutic approaches to cross it. Mol. Membr. Biol. 31 (2014), 152–167.
9. [9] Wisse, E., Braet, F., Luo, D., De Zanger, R., Jans, D., Crabbe, E., Vermoesen, A., Structure and function of sinusoidal lining cells in the liver. Toxicol. Pathol. 24 (1996), 100–111.
10. [10] Cogger, V.C., McNerney, G.P., Nyunt, T., DeLeve, L.D., McCourt, P., Smedsrod, B., Le Couteur, D.G., Huser, T.R., Three-dimensional structured illumination microscopy of liver sinusoidal endothelial cell fenestrations. J. Struct. Biol. 171 (2010), 382–388.
11. [11] Krutzfeldt, A., Spahr, R., Mertens, S., Siegmund, B., Piper, H.M., Metabolism of exogenous substrates by coronary endothelial cells in culture. J. Mol. Cell. Cardiol. 22 (1990), 1393–1404.
12. [12] Culic, O., Gruwel, M.L., Schrader, J., Energy turnover of vascular endothelial cells. Am. J. Phys. 273 (1997), C205–C213.
13. [13] Peters, K., Kamp, G., Berz, A., Unger, R.E., Barth, S., Salamon, A., Rychly, J., Kirkpatrick, C.J., Changes in human endothelial cell energy metabolic capacities during in vitro cultivation. The role of “aerobic glycolysis” and proliferation. Cell. Physiol. Biochem. 24 (2009), 483–492.
14. [14] De Bock, K., Georgiadou, M., Schoors, S., Kuchnio, A., Wong, B.W., Cantelmo, A.R., Quaegebeur, A., Ghesquiere, B., Cauwenberghs, S., Eelen, G., Phng, L.K., Betz, I., Tembuyser, B., Brepoels, K., Welti, J., Geudens, I., Segura, I., Cruys, B., Bifari, F., Decimo, I., Blanco, R., Wyns, S., Vangindertael, J., Rocha, S., Collins, R.T., Munck, S., Daelemans, D., Imamura, H., Devlieger, R., Rider, M., Van Veldhoven, P.P., Schuit, F., Bartrons, R., Hofkens, J., Fraisl, P., Telang, S., Deberardinis, R.J., Schoonjans, L., Vinckier, S., Chesney, J., Gerhardt, H., Dewerchin, M., Carmeliet, P., Role of PFKFB3-driven glycolysis in vessel sprouting. Cell 154 (2013), 651–663.
15. [15] Vandekeere, S., Dewerchin, M., Carmeliet, P., Angiogenesis revisited: an overlooked role of endothelial cell metabolism in vessel sprouting. Microcirculation 22 (2015), 509–517.
16. [16] Huang, Y., Lei, L., Liu, D., Jovin, I., Russell, R., Johnson, R.S., Di Lorenzo, A., Giordano, F.J., Normal glucose uptake in the brain and heart requires an endothelial cell-specific HIF-1alpha-dependent function. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 17478–17483.
17. [17] Shah, K., Desilva, S., Abbruscato, T., The role of glucose transporters in brain disease: diabetes and Alzheimer's disease. Int. J. Mol. Sci. 13 (2012), 12629–12655.
18. [18] Rajendran, P., Rengarajan, T., Thangavel, J., Nishigaki, Y., Sakthisekaran, D., Sethi, G., Nishigaki, I., The vascular endothelium and human diseases. Int. J. Biol. Sci. 9 (2013), 1057–1069.
19. [19] Brownlee, M., Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001), 813–820.
20. [20] Medina, R.A., Owen, G.I., Glucose transporters: expression, regulation and cancer. Biol. Res. 35 (2002), 9–26.
21. [21] Szablewski, L., Expression of glucose transporters in cancers. Biochim. Biophys. Acta 1835 (2013), 164–169.
22. [22] Calvo, M.B., Figueroa, A., Pulido, E.G., Campelo, R.G., Aparicio, L.A., Potential role of sugar transporters in cancer and their relationship with anticancer therapy. Int. J. Endocrinol., 2010, 2010 pii:205357.
23. [23] Wang, J., Alexanian, A., Ying, R., Kizhakekuttu, T.J., Dharmashankar, K., Vasquez-Vivar, J., Gutterman, D.D., Widlansky, M.E., Acute exposure to low glucose rapidly induces endothelial dysfunction and mitochondrial oxidative stress: role for AMP kinase. Arterioscler. Thromb. Vasc. Biol. 32 (2012), 712–720.
24. [24] Szewczyk, A., Jarmuszkiewicz, W., Koziel, A., Sobieraj, I., Nobik, W., Lukasiak, A., Skup, A., Bednarczyk, P., Drabarek, B., Dymkowska, D., Wrzosek, A., Zablocki, K., Mitochondrial mechanisms of endothelial dysfunction. Pharmacol. Rep. 67 (2015), 704–710.
25. [25] Torimoto, K., Okada, Y., Mori, H., Tanaka, Y., Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc. Diabetol., 12, 2013, 1.
26. [26] Augustin, R., The protein family of glucose transport facilitators: it's not only about glucose after all. IUBMB Life 62 (2010), 315–333.
27. [27] Scheepers, A., Joost, H.G., Schurmann, A., The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. JPEN J. Parenter. Enteral Nutr. 28 (2004), 364–371.
28. [28] Mueckler, M., Thorens, B., The SLC2 (GLUT) family of membrane transporters. Mol. Asp. Med. 34 (2013), 121–138.
29. [29] Debosch, B.J., Chen, Z., Saben, J.L., Finck, B.N., Moley, K.H., Glucose transporter 8 (GLUT8) mediates fructose-induced de novo lipogenesis and macrosteatosis. J. Biol. Chem. 289 (2014), 10989–10998.
30. [30] Wilson-O'Brien, A.L., Patron, N., Rogers, S., Evolutionary ancestry and novel functions of the mammalian glucose transporter (GLUT) family. BMC Evol. Biol., 10, 2010, 152.
31. [31] Gould, G.W., Holman, G.D., The glucose transporter family: structure, function and tissue-specific expression. Biochem. J. 295 (1993), 329–341.
32. [32] Huang, S., Czech, M.P., The GLUT4 glucose transporter. Cell Metab. 5 (2007), 237–252.
33. [33] Sajja, R.K., Prasad, S., Cucullo, L., Impact of altered glycaemia on blood-brain barrier endothelium: an in vitro study using the hCMEC/D3 cell line. Fluids Barriers CNS, 11, 2014, 8.
34. [34] Elfeber, K., Kohler, A., Lutzenburg, M., Osswald, C., Galla, H.J., Witte, O.W., Koepsell, H., Localization of the Na +-D-glucose cotransporter SGLT1 in the blood-brain barrier. Histochem. Cell Biol. 121 (2004), 201–207.
35. [35] Vrhovac, I., Balen Eror, D., Klessen, D., Burger, C., Breljak, D., Kraus, O., Radovic, N., Jadrijevic, S., Aleksic, I., Walles, T., Sauvant, C., Sabolic, I., Koepsell, H., Localizations of Na(+)-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart. Pflugers Arch. 467 (2015), 1881–1898.
36. [36] Warboys, C.M., de Luca, A., Amini, N., Luong, L., Duckles, H., Hsiao, S., White, A., Biswas, S., Khamis, R., Chong, C.K., Cheung, W.M., Sherwin, S.J., Bennett, M.R., Gil, J., Mason, J.C., Haskard, D.O., Evans, P.C., Disturbed flow promotes endothelial senescence via a p53-dependent pathway. Arterioscler. Thromb. Vasc. Biol. 34 (2014), 985–995.
37. [37] Zhu, C.H., Mouly, V., Cooper, R.N., Mamchaoui, K., Bigot, A., Shay, J.W., Di Santo, J.P., Butler-Browne, G.S., Wright, W.E., Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies. Aging Cell 6 (2007), 515–523.
38. [38] Huggett, J.F., Foy, C.A., Benes, V., Emslie, K., Garson, J.A., Haynes, R., Hellemans, J., Kubista, M., Mueller, R.D., Nolan, T., Pfaffl, M.W., Shipley, G.L., Vandesompele, J., Wittwer, C.T., Bustin, S.A., The digital MIQE guidelines: minimum information for publication of quantitative digital PCR experiments. Clin. Chem. 59 (2013), 892–902.
39. [39] Chen, J.Q., Heldman, M.R., Herrmann, M.A., Kedei, N., Woo, W., Blumberg, P.M., Goldsmith, P.K., Absolute quantitation of endogenous proteins with precision and accuracy using a capillary Western system. Anal. Biochem. 442 (2013), 97–103.
40. [40] Ziegler, K., Kerimi, A., Poquet, L., Williamson, G., Butyric acid increases transepithelial transport of ferulic acid through upregulation of the monocarboxylate transporters SLC16A1 (MCT1) and SLC16A3 (MCT4). Arch. Biochem. Biophys. 599 (2016), 3–12.
41. [41] McDonough, P.M., Agustin, R.M., Ingermanson, R.S., Loy, P.A., Buehrer, B.M., Nicoll, J.B., Prigozhina, N.L., Mikic, I., Price, J.H., Quantification of lipid droplets and associated proteins in cellular models of obesity via high-content/high-throughput microscopy and automated image analysis. Assay Drug Dev. Technol. 7 (2009), 440–460.
42. [42] Montecinos, V., Guzman, P., Barra, V., Villagran, M., Munoz-Montesino, C., Sotomayor, K., Escobar, E., Godoy, A., Mardones, L., Sotomayor, P., Guzman, C., Vasquez, O., Gallardo, V., van Zundert, B., Bono, M.R., Onate, S.A., Bustamante, M., Carcamo, J.G., Rivas, C.I., Vera, J.C., Vitamin C is an essential antioxidant that enhances survival of oxidatively stressed human vascular endothelial cells in the presence of a vast molar excess of glutathione. J. Biol. Chem. 282 (2007), 15506–15515.
43. [43] Giugliano, D., Ceriello, A., Esposito, K., Glucose metabolism and hyperglycemia. Am. J. Clin. Nutr. 87 (2008), 217S–222S.
44. [44] McGinn, S., Poronnik, P., King, M., Gallery, E.D., Pollock, C.A., High glucose and endothelial cell growth: novel effects independent of autocrine TGF-beta 1 and hyperosmolarity. Am. J. Phys. Cell Physiol. 284 (2003), C1374–C1386.
45. [45] Varma, S., Lal, B.K., Zheng, R., Breslin, J.W., Saito, S., Pappas, P.J., Hobson, R.W. 2nd, Duran, W.N., Hyperglycemia alters PI3k and Akt signaling and leads to endothelial cell proliferative dysfunction. Am. J. Physiol. Heart Circ. Physiol. 289 (2005), H1744–H1751.
46. [46] Ying, C., Sui-Xin, L., Kang-Ling, X., Wen-Liang, Z., Lei, D., Yuan, L., Fan, Z., Chen, Z., MicroRNA-492 reverses high glucose-induced insulin resistance in HUVEC cells through targeting resistin. Mol. Cell. Biochem. 391 (2014), 117–125.
47. [47] Burgin-Maunder, C.S., Brooks, P.R., Russell, F.D., Omega-3 fatty acids modulate Weibel-Palade body degranulation and actin cytoskeleton rearrangement in PMA-stimulated human umbilical vein endothelial cells. Mar. Drugs 11 (2013), 4435–4450.
48. [48] Qi, C., Pekala, P.H., The influence of mRNA stability on glucose transporter (GLUT1) gene expression. Biochem. Biophys. Res. Commun. 263 (1999), 265–269.
49. [49] Bentley, J., Itchayanan, D., Barnes, K., McIntosh, E., Tang, X., Downes, C.P., Holman, G.D., Whetton, A.D., Owen-Lynch, P.J., Baldwin, S.A., Interleukin-3-mediated cell survival signals include phosphatidylinositol 3-kinase-dependent translocation of the glucose transporter GLUT1 to the cell surface. J. Biol. Chem. 278 (2003), 39337–39348.
50. [50] Asano, T., Katagiri, H., Takata, K., Lin, J.L., Ishihara, H., Inukai, K., Tsukuda, K., Kikuchi, M., Hirano, H., Yazaki, Y., et al. The role of N-glycosylation of GLUT1 for glucose transport activity. J. Biol. Chem. 266 (1991), 24632–24636.
51. [51] Asano, T., Takata, K., Katagiri, H., Ishihara, H., Inukai, K., Anai, M., Hirano, H., Yazaki, Y., Oka, Y., The role of N-glycosylation in the targeting and stability of GLUT1 glucose transporter. FEBS Lett. 324 (1993), 258–261.
52. [52] Khayat, Z.A., McCall, A.L., Klip, A., Unique mechanism of GLUT3 glucose transporter regulation by prolonged energy demand: increased protein half-life. Biochem. J. 333 (1998), 713–718.
53. [53] Weisova, P., Concannon, C.G., Devocelle, M., Prehn, J.H., Ward, M.W., Regulation of glucose transporter 3 surface expression by the AMP-activated protein kinase mediates tolerance to glutamate excitation in neurons. J. Neurosci. 29 (2009), 2997–3008.
54. [54] Verdegem, D., Moens, S., Stapor, P., Carmeliet, P., Endothelial cell metabolism: parallels and divergences with cancer cell metabolism. Cancer Metab., 2, 2014, 19.
55. [55] Purcell, S.H., Aerni-Flessner, L.B., Willcockson, A.R., Diggs-Andrews, K.A., Fisher, S.J., Moley, K.H., Improved insulin sensitivity by GLUT12 overexpression in mice. Diabetes 60 (2011), 1478–1482.
56. [56] Pujol-Gimenez, J., Perez, A., Reyes, A.M., Loo, D.D., Lostao, M.P., Functional characterization of the human facilitative glucose transporter 12 (GLUT12) by electrophysiological methods. Am. J. Phys. Cell Physiol. 308 (2015), C1008–C1022.
57. [57] Pardridge, W.M., Boado, R.J., Farrell, C.R., Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. J. Biol. Chem. 265 (1990), 18035–18040.
58. [58] Ohtsuki, S., Ikeda, C., Uchida, Y., Sakamoto, Y., Miller, F., Glacial, F., Decleves, X., Scherrmann, J.M., Couraud, P.O., Kubo, Y., Tachikawa, M., Terasaki, T., Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model. Mol. Pharm. 10 (2013), 289–296.
59. [59] Mimura, I., Nangaku, M., Kanki, Y., Tsutsumi, S., Inoue, T., Kohro, T., Yamamoto, S., Fujita, T., Shimamura, T., Suehiro, J., Taguchi, A., Kobayashi, M., Tanimura, K., Inagaki, T., Tanaka, T., Hamakubo, T., Sakai, J., Aburatani, H., Kodama, T., Wada, Y., Dynamic change of chromatin conformation in response to hypoxia enhances the expression of GLUT3 (SLC2A3) by cooperative interaction of hypoxia-inducible factor 1 and KDM3A. Mol. Cell. Biol. 32 (2012), 3018–3032.
60. [60] Rajah, T.T., Olson, A.L., Grammas, P., Differential glucose uptake in retina- and brain-derived endothelial cells. Microvasc. Res. 62 (2001), 236–242.
61. [61] Cucullo, L., Hossain, M., Puvenna, V., Marchi, N., Janigro, D., The role of shear stress in blood-brain barrier endothelial physiology. BMC Neurosci., 12, 2011, 40.
62. [62] Giacco, F., Brownlee, M., Oxidative stress and diabetic complications. Circ. Res. 107 (2010), 1058–1070.
63. [63] Doddaballapur, A., Michalik, K.M., Manavski, Y., Lucas, T., Houtkooper, R.H., You, X., Chen, W., Zeiher, A.M., Potente, M., Dimmeler, S., Boon, R.A., Laminar shear stress inhibits endothelial cell metabolism via KLF2-mediated repression of PFKFB3. Arterioscler. Thromb. Vasc. Biol. 35 (2015), 137–145.
64. [64] Kim, B., Lee, H., Kawata, K., Park, J.Y., Exercise-mediated wall shear stress increases mitochondrial biogenesis in vascular endothelium. PLoS One, 9, 2014, e111409.
65. [65] Simpson, I.A., Appel, N.M., Hokari, M., Oki, J., Holman, G.D., Maher, F., Koehler-Stec, E.M., Vannucci, S.J., Smith, Q.R., Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited. J. Neurochem. 72 (1999), 238–247.
66. [66] Artwohl, M., Brunmair, B., Furnsinn, C., Holzenbein, T., Rainer, G., Freudenthaler, A., Porod, E.M., Huttary, N., Baumgartner-Parzer, S.M., Insulin does not regulate glucose transport and metabolism in human endothelium. Eur. J. Clin. Investig. 37 (2007), 643–650.
67. [67] Alpert, E., Gruzman, A., Riahi, Y., Blejter, R., Aharoni, P., Weisinger, G., Eckel, J., Kaiser, N., Sasson, S., Delayed autoregulation of glucose transport in vascular endothelial cells. Diabetologia 48 (2005), 752–755.
68. [68] Wegner, M., Neddermann, D., Piorunska-Stolzmann, M., Jagodzinski, P.P., Role of epigenetic mechanisms in the development of chronic complications of diabetes. Diabetes Res. Clin. Pract. 105 (2014), 164–175.
69. [69] Pouliot, J.F., Beliveau, R., Palmitoylation of the glucose transporter in blood-brain barrier capillaries. Biochim. Biophys. Acta 1234 (1995), 191–196.
70. [70] Ohtsubo, K., Takamatsu, S., Gao, C., Korekane, H., Kurosawa, T.M., Taniguchi, N., N-glycosylation modulates the membrane sub-domain distribution and activity of glucose transporter 2 in pancreatic beta cells. Biochem. Biophys. Res. Commun. 434 (2013), 346–351.
71. [71] Rungaldier, S., Oberwagner, W., Salzer, U., Csaszar, E., Prohaska, R., Stomatin interacts with GLUT1/SLC2A1, band 3/SLC4A1, and aquaporin-1 in human erythrocyte membrane domains. Biochim. Biophys. Acta 1828 (2013), 956–966.
72. [72] Coughlan, K.A., Valentine, R.J., Ruderman, N.B., Saha, A.K., Nutrient excess in AMPK downregulation and insulin resistance. J. Endocrinol. Diabetes Obes., 1, 2013, 1008.
73. [73] Ido, Y., Carling, D., Ruderman, N., Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. Diabetes 51 (2002), 159–167.
74. [74] Guo, X., Geng, M., Du, G., Glucose transporter 1, distribution in the brain and in neural disorders: its relationship with transport of neuroactive drugs through the blood-brain barrier. Biochem. Genet. 43 (2005), 175–187.
75. [75] Barros, L.F., Bittner, C.X., Loaiza, A., Porras, O.H., A quantitative overview of glucose dynamics in the gliovascular unit. Glia 55 (2007), 1222–1237.
76. [76] Michel, C.C., Curry, F.E., Microvascular permeability. Physiol. Rev. 79:3 (1999), 703–761.
77. [77] Sukriti, S., Tauseef, M., Yazbeck, P., Mehta, D., Mechanisms regulating endothelial permeability. Pulm Circ. 4 (2014), 535–551.
78. [78] Gerritsen, M.E., Functional heterogeneity of vascular endothelial cells. Biochem. Pharmacol. 36 (1987), 2701–2711.